Regular physical exercise induces beneficial effects on the cardiovascular system. To evaluate the relationships between endothelial function, evaluated as post ischemic reactive hyperemia, and physical performance (as maximal oxygen consumption , VO2max), we studied 15 healthy male volunteers, (mean age 26,4Ϯ5 years; B.P. 107/75Ϯ27/6 mmHg) used to perform a mixed aerobic and anaerobic exercise, 3 times weekly for 90 minutes.
The effects of Ca 2ϩ channel antagonist nimodipine (also known as phosphodiesterase-1 inhibitor-PDE1) were examined on coronary flow, endothelial NO production (nitrite outflow) and superoxide anion production. The experiments were performed on isolated rat hearts from male Wistar albino rats (BM about 200 g, 8 weeks) and perfused with buffer at constant pressure. The nitrite outflow and superoxide anion release were estimated by spectrophotometry. The coronary autoregulation (CA) was investigated with follow-up of coronary perfusion pressure (CPP) changes from 40 to 120 cm H 2 O. After first sequence of CPP changes (basic protocol), the hearts were perfused with nimodipine (in concentration known to elicit PDE1 inhibition, 2 mM) alone or in combination with nitric oxide synthase inhibitor (L-NAME, 30 mM increase of reactive oxygen species in vessels wall. The aim of this study was to evaluate the impact of poisoning with lead in hypertensive doses (50 or 100 ppm in drinking water for three months) on the basal and stimulated released NO effect in isolated and perfused rat mesenteric bed according to the red-ox system activity in aorta and levels of NO and endogenous vasoactive agents (endothelin-1 and prostaglandin F 2␣ ) in the blood. Unexpectedly, rats given 50 ppm of lead have demonstrated an increase of maximal vascular response to N-w -nitro-L-arginine (pϽ0.01) and acetylcholine (pϽ0.05), the shift to the left of the doseresponse curve for ACh and a decrease of plasma endothelin-1 (pϽ0.05) concentration in comparison to controls. Lipid peroxides and glutathione in aorta and blood nitric oxide concentrations were significant increased in rats given both 50 and 100 ppm of lead. We conclude, that lead in small hypertensive dose, in contrast to higher hypertensive dose, enhances vascular effect of NO in rat mesenteric bed. The aim of this study was to examine the role of the serine/threonine kinase, Akt, signaling pathway in mediating interactions between angiotensin II (Ang II) and insulin-like growth factor-1 (IGF-1) in the regulation of nitric-oxide synthase (NOS) activity in vascular smooth muscle cells (VSMC). To investigate the role of Ang II, aortic and heart tissue obtained from transgenic rats overexpressing the mouse Ren-2 gene (hypertensive mREN rats) and Sprague-Dowley (SD) rats were treated with the AT 1 receptor agonist, Valsratan (30 mg/kg/day). In VSMC obtained from the 2 models, exposure to IGF-1 (100 nM) for 10 min resulted in increased NOS activity and NO production. IGF-1 treatment induces Akt phosphorylation at Ser 473 and Thr 308 , as well as Akt kinase activity. Pretreatment with Ang II (100 nM) for 5 min substantially decreased these IGF-1 effects; NOS activity was decreased in mREN rats compared to SD animals. Following the treatment of mREN animals with Valsartan for 2 weeks, the NOS activity was found to be similar to the levels in SD controls. Akt phosphorylation at Ser 473 was attenuated in aortic tissue in untreated mREN when compared to SD, while no differences were found in the phosphorylation at Thr 308 between the two strains. In heart tissue the level of Akt phosphorylation at Ser 473 was increased in Valsartan treated animals compared to untreated mREN. These results demonstrate a role for Akt in the Ang II/IGF-1 regulation of NOS in VSMC and cardiac tissue, and show that the AT 1 blocker was successful in correcting some of the abnormalities.
Key Words: Insulin-like growth factor-1, angiotensin II, nitric-oxide synthase Barbara M Suwelack, Helge Hohage. Medizinische Klinik und Poliklinik D, Universitaetsklinikum Muenster, Muenster, NRW, Germany. Side effects of cyclosporine A (CsA) treatment, such as vasoconstriction and reduced renal plasma flow, are partly endothelium-dependent. Allopurinol improves endothelial function in diabetic and hypertensive patients. We examined the effects of allopurinol-application (50 mg/kg over 14 days) on arterial blood pressure, renal blood flow and vasoreactivity of CsA-treated (8 mg/kg over 14 days) Wistar rats.
P-101 DOES ALLOPURINOL PREVENT SIDE EFFECTS OF CYCLOSPORINE A TREATRMENT?
Mean arterial pressure (MAP) of CsA-treated rats was 106 Ϯ 4 mmHg (MAP of CsA ϩ allopurinol-treated rats: 103 Ϯ 4 mmHg), renal plasma flow was 6.3 Ϯ 1.5 ml/min in CsA-treated rats as compared to 5.3 Ϯ 1.1 ml/min in rats treated with CsA ϩ allopurinol. Bolus injection of norfenefrin (0.1 mg/kg) increased MAP to 168 Ϯ 9 (CsA-group) and to 128 Ϯ 8 mmHg (CsA ϩ allopurinol-group). The elevation of blood pressure was significantly higher in the CsA-treated-group than in the CsAϩallopurinol-treated animals (62 Ϯ 6 vs. 24 Ϯ 5 mmHg, pϽ0.05), while renal plasma flow decreased to 1.3 Ϯ 0.5 (CsA-group) and to 3.5 Ϯ 0.7 ml/min respectively (CsA ϩ allopurinol-group). The difference of the decrease of renal plasma flow between the groups was significant (pϽ0.05).
Allopurinol seems to have beneficial effects on vasoreactivity and renal blood flow in CsA-treated animals and might attenuate CsAinduced nephrotoxicity.
